Across the UK, US, and Europe, oxygen therapy is moving out of the hospital and into the home. Over 1.5 million Americans now ...

CytoSorbents plans to ask Canadian health authorities to reconsider rejecting the company's license application for DrugSorb-ATR, an investigational device designed to reduce the severity of bleeding ...

Edmondson has been the lead investigator on or participated on research teams behind more than 50 clinical studies showing ...

The Justice Department today announced the results of its 2025 National Health Care Fraud Takedown, which resulted in ...

The voices of more than 21,000 choir singers rang out in the rain in Estonia, and a huge crowd of spectators erupted in ...

Both near and far infrared light can penetrate deep into tissue to stimulate cellular activity, and with consistent use, it’s ...

The wearable, transcutaneous neurostimulation device delivers personalized therapy using a proprietary AI algorithm.

Nearly two million people worldwide have lost the simple ability to feel steady. Now researchers have developed an ...

Achieve faster recovery with the MOVE+ Pro! From soothing tendonitis to easing joint pain, this portable red light therapy ...

Onward Medical announced today that it submitted its ARC-EX system for expanded FDA indication and for CE mark approval.

CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions in the intensive care unit and cardiac surgery, today provided a regulatory update on ...